Somaliq Pen 60IU

Description

Somaliq Pen 60IU is a prescription medicine that is used to improve blood sugar control in adults and children with diabetes mellitus.

Composition

The active ingredient in Somaliq Pen 60IU is Insulin Glulisine. Each pen contains 60 International Units (IU) of Insulin Glulisine.

Indications

Somaliq Pen 60IU is indicated for the treatment of type 1 diabetes (a condition in which the body does not produce insulin) and type 2 diabetes (a condition in which the body does not use insulin normally).

Contraindications

Somaliq Pen 60IU is contraindicated in patients who are allergic to insulin glulisine or any of the other ingredients of this medicine. It should not be used during episodes of hypoglycemia (low blood sugar).

Administration

Somaliq Pen 60IU is administered subcutaneously, usually into the fatty tissue just under the skin. It should be administered within 15 minutes before a meal or immediately after a meal.

Dosage

The dosage of Somaliq Pen 60IU should be individualized based on the patient’s metabolic needs, blood glucose monitoring results, and glycemic control goal. The dosage can be adjusted under the supervision of a healthcare provider.

Overdose

An overdose of Somaliq Pen 60IU can cause hypoglycemia. If this occurs, the patient should consume a quick source of sugar such as glucose gel, fruit juice, or a non-diet soda. Severe hypoglycemia may cause unconsciousness, seizures, or death. If you suspect an overdose, seek immediate medical attention.

Side Effects

Common side effects of Somaliq Pen 60IU include hypoglycemia, allergic reactions, injection site reactions, lipodystrophy (a disorder of adipose tissue), and weight gain. Less common but serious side effects include severe hypoglycemia, serious allergic reactions, and hypokalemia (low potassium levels in the blood).

Storage

Somaliq Pen 60IU should be stored in a refrigerator between 2°C and 8°C. Do not freeze. After first use, the pen can be kept at room temperature, below 30°C, for up to 28 days. Protect from light and excessive heat.

Warnings and Precautions

Somaliq Pen 60IU should be used with caution in patients with renal or hepatic impairment, in patients with hypoglycemia unawareness, in patients who have had hypersensitivity reactions to insulin, and in patients with certain medical conditions that may increase the risk of hypoglycemia or hypokalemia.

Interactions

Some medications may affect the glucose lowering effect of Somaliq Pen 60IU, including corticosteroids, diuretics, sympathomimetic agents, and certain hormone therapies. Alcohol may increase the risk of hypoglycemia. Always inform your healthcare provider about all the medications you are taking.

Pregnancy and Lactation

Somaliq Pen 60IU should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether Somaliq Pen 60IU is excreted in human milk. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Disclaimer

This is a summary and does not have all possible information about Somaliq Pen 60IU. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.